(Q37832787)

24 August 2017

1 reference

title

The evolving approach to paediatric myocarditis: a review of the current literature (English)

1 reference

24 August 2017

1 reference

Lindsay J May

1

1 reference

PubMed ID

21272427

24 August 2017

David J Patton

series ordinal

2

1 reference

PubMed ID

21272427

24 August 2017

Deborah S Fruitman

series ordinal

3

1 reference

24 August 2017

28 January 2011

1 reference

24 August 2017

Cardiology in the Young

1 reference

24 August 2017

21

1 reference

24 August 2017

3

1 reference

24 August 2017

241-251

1 reference

Complications of endomyocardial biopsy in children

24 August 2017

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Long-term follow-up of patients paragraph sign with acute myocarditis by magnetic paragraph sign resonance imaging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiovascular magnetic resonance of myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

T2-weighted cardiovascular magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiovascular magnetic resonance in myocarditis: A JACC White Paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Noninvasive imaging in myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Suspected chronic myocarditis at cardiac MR: diagnostic accuracy and association with immunohistologically detected inflammation and viral persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Non-invasive imaging in the diagnosis of acute viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

N-terminal pro-B-type natriuretic peptide: reference plasma levels from birth to adolescence. Elevated levels at birth and in infants and children with heart diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

NT-proBNP as a marker for persistent cardiac disease in children with history of dilated cardiomyopathy and myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Mechanical circulatory support for the treatment of children with acute fulminant myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Inflammatory cardiomyopathy (myocarditis): which patients should be treated with anti-inflammatory therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Fulminant myocarditis successfully treated with high-dose immunoglobulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Design and implementation of the North American Pediatric Cardiomyopathy Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Myocarditis: basic and clinical aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Clinical myocarditis masquerading as acute coronary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Human parvovirus B19 infection in infancy associated with acute and chronic lymphocytic myocarditis and high cytokine levels: report of 3 cases and review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Pediatric myocarditis: presenting clinical characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Fulminant myocarditis associated with pandemic H1N1 influenza A virus in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

The current status of immune modulating therapy for myocarditis: a case of acute parvovirus myocarditis treated with intravenous immunoglobulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Intravenous immunoglobulin treatment for acute fulminant inflammatory cardiomyopathy: series of six patients and review of literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Incidence, causes, and outcomes of dilated cardiomyopathy in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Viral persistence in the myocardium is associated with progressive cardiac dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Coxsackie virus myopericarditis. A microbiological and clinical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

A systematic review of intravenous gamma globulin for therapy of acute myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Immunosuppressive therapy in acute myocarditis: an 18 year systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Myocarditis, microbes and autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Immunosuppressive treatment for myocarditis and borderline myocarditis in children with ventricular ectopic rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Outcome of acute fulminant myocarditis in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Technology insight: Use of ventricular assist devices in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiac ECMO for biventricular hearts after paediatric open heart surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Outcome of pediatric patients treated with extracorporeal life support after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Extracorporeal membrane oxygenation for the support of infants, children, and young adults with acute myocarditis: a review of the Extracorporeal Life Support Organization registry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Children with fulminant myocarditis rescued with extracorporeal membrane oxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Immunosuppressive treatment for myocarditis and dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Immunosuppressive therapy in experimental and clinical myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Lymphocytic myocarditis presenting as unexplained ventricular arrhythmias: diagnosis with endomyocardial biopsy and response to immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Successful bridge to recovery with 120 days of mechanical support in an infant with myocarditis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Ventricular assist devices in children: current achievements and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Sudden death in young adults: a 25-year review of autopsies in military recruits

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiac pathology in 2007 consecutive forensic autopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Pediatric myocarditis: emergency department clinical findings and diagnostic evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Molecular biology and pathogenesis of viral myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Acute myocarditis in infants. Initial presentation

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Mechanical circulatory support for fulminant myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Diagnosis and management of pediatric myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Cardiac Output Response to Continuous Positive Airway Pressure in Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Carvedilol as therapy in pediatric heart failure: an initial multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

High-dose intravenous immunoglobulin in the treatment of acute myocarditis. A case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Beta-blocker treatment of dilated cardiomyopathy. Beneficial effect of carteolol in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Complication rate of right ventricular endomyocardial biopsy via the femoral approach: a retrospective and prospective study analyzing 3048 diagnostic procedures over an 11-year period.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

FATAL COXSACKIEVIRUS A16 INFECTION

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Gamma-globulin treatment of acute myocarditis in the pediatric population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Favorable effects of immunosuppressive therapy in children with dilated cardiomyopathy and active myocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

Myocardial edema--a new clinical entity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Cardiac troponins in pediatric myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

ACUTE MYOCARDITIS IN INFANCY AND CHILDHOOD

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Predictors of outcome of myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Acute myocarditis. Rapid diagnosis by PCR in children

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Advances in the understanding of myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

The ineffectiveness of immunosuppressive therapy in lymphocytic myocarditis: an overview

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Right ventricular dysfunction: an independent predictor of adverse outcome in patients with myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Cardiac troponin T: a marker in the diagnosis of acute myocarditis in children

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Treatment and outcome of biopsy-proven fulminant myocarditis in adults

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Treatment of acute inflammatory cardiomyopathy with intravenous immunoglobulin ameliorates left ventricular function associated with suppression of inflammatory cytokines and decreased oxidative stress

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Myocarditis: the Dallas criteria

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Dilated cardiomyopathy and thrombo-embolism

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Effect of continuous positive airway pressure on intrathoracic and left ventricular transmural pressures in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Neonatal myocarditis presenting as an apparent life threatening event

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Corticosteroid therapy for ventricular tachycardia in children with silent lymphocytic myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Effects of immunosuppressive therapy in biopsy-proved myocarditis and borderline myocarditis on left ventricular function

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

High-dose immunoglobulin G therapy for fulminant myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Outcomes for children with acute myocarditis

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

Immunosuppressive therapy in the management of acute myocarditis in children: a clinical trial

1 reference

https://api.crossref.org/works/10.1017%2FS1047951110001964

7 January 2021

10.1017/S1047951110001964

Identifiers

DOI

1 reference

24 August 2017

1 reference

PubMed ID

21272427